Evoke Pharma Return on Investment 2012-2024 | EVOK
Current and historical return on investment (ROI) values for Evoke Pharma (EVOK) over the last 10 years.
| Evoke Pharma ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-09-30 |
$-0.01B |
|
inf% |
| 2024-06-30 |
$-0.01B |
|
-700.00% |
| 2024-03-31 |
$-0.01B |
|
-320.00% |
| 2023-12-31 |
$-0.01B |
|
-188.24% |
| 2023-09-30 |
$-0.01B |
$0.00B |
-123.08% |
| 2023-06-30 |
$-0.01B |
$0.01B |
-96.97% |
| 2023-03-31 |
$-0.01B |
$0.01B |
-82.05% |
| 2022-12-31 |
$-0.01B |
$0.01B |
-82.05% |
| 2022-09-30 |
$-0.01B |
$0.01B |
-82.05% |
| 2022-06-30 |
$-0.01B |
$0.01B |
-84.21% |
| 2022-03-31 |
$-0.01B |
$0.01B |
-86.49% |
| 2021-12-31 |
$-0.01B |
$0.01B |
-83.72% |
| 2021-09-30 |
$-0.01B |
$0.01B |
-100.00% |
| 2021-06-30 |
$-0.01B |
$0.01B |
-138.46% |
| 2021-03-31 |
$-0.01B |
$0.01B |
-329.41% |
| 2020-12-31 |
$-0.01B |
$0.00B |
-1300.00% |
| 2020-09-30 |
$-0.01B |
$0.00B |
-2400.00% |
| 2020-06-30 |
$-0.01B |
$0.00B |
-2400.00% |
| 2020-03-31 |
$-0.01B |
|
inf% |
| 2019-12-31 |
$-0.01B |
|
inf% |
| 2019-09-30 |
$-0.01B |
|
inf% |
| 2019-06-30 |
$-0.01B |
|
inf% |
| 2019-03-31 |
$-0.01B |
|
inf% |
| 2018-12-31 |
$-0.01B |
|
inf% |
| 2018-09-30 |
$-0.01B |
|
inf% |
| 2018-06-30 |
$-0.01B |
|
inf% |
| 2018-03-31 |
$-0.01B |
|
inf% |
| 2017-12-31 |
$-0.01B |
|
inf% |
| 2017-09-30 |
$-0.01B |
|
inf% |
| 2017-06-30 |
$-0.01B |
|
inf% |
| 2017-03-31 |
$-0.01B |
|
inf% |
| 2016-12-31 |
$-0.01B |
|
-1000.00% |
| 2016-09-30 |
$-0.01B |
|
-366.67% |
| 2016-06-30 |
$-0.01B |
|
-218.18% |
| 2016-03-31 |
$-0.01B |
$0.00B |
-165.52% |
| 2015-12-31 |
$-0.01B |
$0.01B |
-137.14% |
| 2015-09-30 |
$-0.01B |
$0.01B |
-120.00% |
| 2015-06-30 |
$-0.01B |
$0.01B |
-173.33% |
| 2015-03-31 |
$-0.01B |
$0.01B |
-226.09% |
| 2014-12-31 |
$-0.01B |
$0.01B |
-157.58% |
| 2014-09-30 |
$-0.01B |
|
-111.63% |
| 2014-06-30 |
$-0.01B |
|
-50.00% |
| 2014-03-31 |
$-0.01B |
$0.02B |
-31.25% |
| 2013-12-31 |
$-0.00B |
$0.02B |
-18.18% |
| 2013-06-30 |
$0.00B |
$0.00B |
nan% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
